CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Accrued Liabilities
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Accrued Liabilities of -$11.49 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2017-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2016-12-31 was $3.69M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2016-09-24 was -$9.29M, a 169.35% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2016-06-25 was -$5.45M, a 147.23% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2016-03-26 was -$444.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued liabilities for fiscal 2016 was -$11.49M, a 181.65% decline from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued liabilities for fiscal 2015 was $14.07M, a 69.83% increase from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued liabilities for fiscal 2014 was $8.28M, a 991.44% increase from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued liabilities for fiscal 2013 was $759.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$5.59M derived: sum of 2 quarters · filed 2017-02-14 | -$11.04M derived: sum of 3 quarters · filed 2017-02-14 | -$11.49M 10-K · filed 2017-02-14 | |||
| 2016-09-24 | -$9.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$14.74M derived: sum of 2 quarters · filed 2016-11-02 | -$15.18M 10-Q · filed 2016-11-02 | -$23.30M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2016-06-25 | -$5.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$5.89M 10-Q · filed 2016-08-03 | -$14.01M derived: sum of 3 quarters · filed 2017-02-14 | -$619.00K derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2016-03-26 | -$444.00K 10-Q · filed 2016-05-04 | -$8.56M derived: sum of 2 quarters · filed 2017-02-14 | $4.83M derived: sum of 3 quarters · filed 2017-02-14 | $16.37M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-12-26 | -$8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $5.27M derived: sum of 2 quarters · filed 2017-02-14 | $16.81M derived: sum of 3 quarters · filed 2017-02-14 | $14.07M 10-K · filed 2017-02-14 | |||
| 2015-09-26 | $13.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $24.93M derived: sum of 2 quarters · filed 2016-11-02 | $22.19M 10-Q · filed 2016-11-02 | $17.12M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-27 | $11.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $8.79M 10-Q · filed 2016-08-03 | $3.72M derived: sum of 3 quarters · filed 2017-02-14 | $7.07M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-28 | -$2.74M 10-Q · filed 2016-05-04 | -$7.81M derived: sum of 2 quarters · filed 2017-02-14 | -$4.47M derived: sum of 3 quarters · filed 2017-02-14 | -$1.39M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-27 | -$5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$1.73M derived: sum of 2 quarters · filed 2017-02-14 | $1.35M derived: sum of 3 quarters · filed 2017-02-14 | $8.28M 10-K · filed 2017-02-14 | |||
| 2014-09-27 | $3.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $6.42M derived: sum of 2 quarters · filed 2015-11-04 | $13.36M 10-Q · filed 2015-11-04 | $10.83M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-28 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $10.01M 10-Q · filed 2015-07-30 | $7.49M derived: sum of 3 quarters · filed 2016-02-12 | $11.59M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-29 | $6.93M 10-Q · filed 2015-04-30 | $4.41M derived: sum of 2 quarters · filed 2016-02-12 | $8.51M derived: sum of 3 quarters · filed 2016-02-12 | $5.87M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-28 | -$2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $1.58M derived: sum of 2 quarters · filed 2016-02-12 | -$1.07M derived: sum of 3 quarters · filed 2016-02-12 | $759.00K 10-K · filed 2016-02-12 | |||
| 2013-09-28 | $4.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $1.46M derived: sum of 2 quarters · filed 2014-10-30 | $3.29M 10-Q · filed 2014-10-30 | -$2.25M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-06-29 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$820.00K 10-Q · filed 2014-08-07 | -$6.35M derived: sum of 3 quarters · filed 2015-02-17 | $1.21M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-03-30 | $1.83M 10-Q · filed 2014-04-30 | -$3.71M derived: sum of 2 quarters · filed 2015-02-17 | $3.86M derived: sum of 3 quarters · filed 2015-02-17 | -$109.00K derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2012-12-29 | -$5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $2.03M derived: sum of 2 quarters · filed 2015-02-17 | -$1.94M derived: sum of 3 quarters · filed 2015-02-17 | -$7.05M 10-K · filed 2015-02-17 | |||
| 2012-09-29 | $7.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $3.60M derived: sum of 2 quarters · filed 2013-10-30 | -$1.52M 10-Q · filed 2013-10-30 | $857.00K derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | -$3.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | -$9.08M 10-Q · filed 2013-07-31 | -$6.71M derived: sum of 3 quarters · filed 2014-02-25 | -$7.68M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | -$5.11M 10-Q · filed 2013-05-08 | -$2.74M derived: sum of 2 quarters · filed 2014-02-25 | -$3.72M derived: sum of 3 quarters · filed 2014-02-25 | -$6.66M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.40M derived: sum of 2 quarters · filed 2014-02-25 | -$1.54M derived: sum of 3 quarters · filed 2014-02-25 | -$1.35M 10-K · filed 2014-02-25 | |||
| 2011-09-24 | -$980.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$3.92M derived: sum of 2 quarters · filed 2012-11-01 | -$3.73M 10-Q · filed 2012-11-01 | -$9.13M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-25 | -$2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$2.75M 10-Q · filed 2012-08-07 | -$8.15M derived: sum of 3 quarters · filed 2013-02-27 | -$7.58M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-26 | $187.00K 10-Q · filed 2012-05-04 | -$1.74M 10-Q · filed 2011-05-04 | -$5.21M derived: sum of 2 quarters · filed 2013-02-27 | -$4.64M derived: sum of 3 quarters · filed 2013-02-27 | $4.28M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2010-12-25 | -$5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$4.83M derived: sum of 2 quarters · filed 2013-02-27 | $4.10M derived: sum of 3 quarters · filed 2013-02-27 | $5.50M 10-K · filed 2013-02-27 | |||
| 2010-09-25 | $567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $9.49M derived: sum of 2 quarters · filed 2011-11-02 | $10.90M 10-Q · filed 2011-11-02 | $11.44M 10-Q · filed 2010-11-04 | $10.12M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-06-26 | $8.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | $10.33M 10-Q · filed 2011-08-03 | $10.16M 10-Q · filed 2010-08-03 | $9.55M derived: sum of 3 quarters · filed 2012-02-27 | $9.71M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-03-27 | $1.40M 10-Q · filed 2011-05-04 | $628.00K derived: sum of 2 quarters · filed 2012-02-27 | $778.00K derived: sum of 3 quarters · filed 2012-02-27 | ||||
| 2009-12-26 | -$776.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$626.00K derived: sum of 2 quarters · filed 2012-02-27 | -$6.67M 10-K · filed 2012-02-27 | ||||
| 2009-09-26 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | -$5.89M 10-Q · filed 2010-11-04 | |||||
| 2009-06-27 | -$6.04M 10-Q · filed 2010-08-03 | ||||||
| 2008-12-27 | $7.32M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |